Synapse - Robert Motzer

Results (160)

Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma

Journal Article

Hakimi, A. A.; Chen, Y. B.; Wren, J.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; Reuter, V. E.; more...
European Urology (2013)

Fulltext@MSK | Save

Serum tumor marker (STM) decline rates during high-dose chemotherapy (HDCT) to predict outcome for germ cell tumor (GCT) patients (pts)

Meeting Abstract

Feldman, D. R.; Voss, M. H.; Jia, X.; Van Alstine, L. J.; Patil, S.; Fischer, P.; Sheinfeld, J.; Bosl, G. J.; Motzer, R. J.
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save

Tumor suppressor screens of 3p chromatin modulators link BAP1 mutations to poor clinical outcomes in clear cell renal cell carcinoma

Meeting Abstract

Hakimi, A. A.; Chen, Y. B.; Wren, J.; Ostrovnaya, I.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; more...
BJU International (2012)

Fulltext@MSK | Save

Improvement in overall survival of patients with advanced renal cell carcinoma: Prognostic factor trend analysis from an international data set of clinical trials

Journal Article

Patil, S.; Manola, J.; Elson, P.; Negrier, S.; Escudier, B.; Eisen, T.; Atkins, M.; Bukowski, R.; Motzer, R. J.
Journal of Urology (2012)

Fulltext@MSK | Save

Systematic classification and prediction of complications after nephrectomy in patients with metastatic renal cell carcinoma (RCC)

Journal Article

Silberstein, J. L.; Adamy, A.; Maschino, A. C.; Ehdaie, B.; Garg, T.; Favaretto, R. L.; Ghoneim, T. P.; Motzer, R. J.; Russo, P.
BJU International (2012)

Fulltext@MSK | Save

Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α

Journal Article

Patil, S.; Figlin, R. A.; Hutson, T. E.; Michaelson, M. D.; Negrier, S.; Kim, S. T.; Huang, X.; Motzer, R. J.
British Journal of Cancer (2012)

Fulltext@MSK | Save

Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma

Journal Article

Molina, A. M.; Feldman, D. R.; Voss, M. H.; Ginsberg, M. S.; Baum, M. S.; Brocks, D. R.; Fischer, P. M.; Trinos, M. J.; Patil, S.; Motzer, R. J.
Cancer (2012)

Fulltext@MSK | Save

Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma

Journal Article

Molina, A. M.; Feldman, D. R.; Ginsberg, M. S.; Kroog, G.; Tickoo, S. K.; Jia, X.; Georges, M.; Patil, S.; Baum, M. S.; Reuter, V. E.; more...
Investigational New Drugs (2012)

Fulltext@MSK | Save

Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: Endpoints for clinical trial design

Journal Article

Feldman, D. R.; Patil, S.; Trinos, M. J.; Carousso, M.; Ginsberg, M. S.; Sheinfeld, J.; Bajorin, D. F.; Bosl, G. J.; Motzer, R. J.
Cancer (2012)

Fulltext@MSK | Save

Clinical features of germ cell tumors (GCT) in men age 50 or older: Successful outcome and tolerability to chemotherapy for advanced disease

Meeting Abstract

Voss, M. H.; Jacobsen, E. P.; Patil, S.; Turkula, S.; Jia, X.; Sheinfeld, J.; Bajorin, D. F.; Bosl, G. J.; Motzer, R. J.; Feldman, D. R.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save